A doxorubicin (DOX)-loaded and light-induced ROS-producing polymeric micelle (D-LRPM), in which light triggers simultaneous DOX-release and endo/lysosomal escape, produces a powerful, spatiotemporally controllable, therapeutic efficacy for tumor treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c5cc09239f | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A multifunctional hyaluronic acid-engineered mesoporous nanoreactor with HO/O self-sufficiency for pH-triggered endo-lysosomal escape and synergetic cancer therapy.
Biomater Adv
December 2024
College of Materials Science and Engineering, Jilin Institute of Chemical Technology, Jilin City 132022, Jilin Province, PR China. Electronic address:
Monotherapy has poor accuracy and is easily restricted by tumor microenvironment (TME). Remodeling components of the TME to activate multimodal cancer therapy with high precision and efficiency is worth exploring. A multifunctional nanoreactor was fabricated by decorating chlorin e6-modified and PEGylated hyaluronic acid bearing diethylenetriamine-conjugated dihydrolipoic acid on the surface of glucose oxidase (GOx)-loaded hollow mesoporous CuS nanoparticles (labeled as GOx@HCuS@HA).
View Article and Find Full Text PDFT Lymphocyte-Macrophage Hybrid Membrane-Coated Biomimetic Nanoparticles Alleviate Myocarditis via Suppressing Pyroptosis by Targeting Gene Silencing.
Int J Nanomedicine
December 2024
Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Article Synopsis
- Nanomedicine using cell membrane coatings has gained interest due to improved targeting and reduced side effects, particularly focusing on treating myocarditis through IRF1-mediated macrophage pyroptosis.
- Researchers created a zeolitic imidazolate framework-8 (ZIF-8) nano-delivery system encapsulating siRNA aimed at IRF1, which was coated with a hybrid membrane from T lymphocytes and macrophages for efficient targeting.
- Findings indicated that the developed nanoparticles effectively delivered siRNA, reduced IRF1 expression, and decreased pyroptosis in macrophages, leading to a significant reduction in myocarditis progression in mice with minimal adverse effects.
Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy.
J Control Release
January 2025
MoE Frontiers Science Center For Precision Oncology, Cancer Centre, Faculty of Health Sciences, University of Macau, Macau, SAR 999078, China. Electronic address:
Ferroptosis, triggered by membrane lipid peroxidation (LPO) and diminished antioxidants, can be induced by intracellular iron (II, Fe). However, the role of nitric oxide (NO) in causing Fe overload for ferroptosis remains uncertain. This study reveals that NO can stimulate endogenous Fe release by upregulating heme oxygenase 1 (HMOX1) expression.
View Article and Find Full Text PDFDevelopment of Dual-Targeted Mixed Micelles Loaded with Celastrol and Evaluation on Triple-Negative Breast Cancer Therapy.
Pharmaceutics
September 2024
Pharmacy Faculty, Hubei University of Chinese Medicine, Wuhan 430065, China.
Considering that the precise delivery of Celastrol (Cst) into mitochondria to induce mitochondrial dysfunction may be a potential approach to improve the therapeutic outcomes of Cst on TNBC, a novel tumor mitochondria dual-targeted mixed-micelle nano-system was fabricated via self-synthesized triphenylphosphonium-modified cholesterol (TPP-Chol) and hyaluronic acid (HA)-modified cholesterol (HA-Chol). The Cst-loaded mixed micelles (Cst@HA/TPP-M) exhibited the characteristics of a small particle size, negative surface potential, high drug loading of up to 22.8%, and sustained drug release behavior.
View Article and Find Full Text PDFBreaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome.
Adv Drug Deliv Rev
November 2024
Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:
In the past decade, nucleic acid therapies have seen a boon in development and clinical translation largely due to advances in nanotechnology that have enabled their safe and targeted delivery. Nanoparticles can protect nucleic acids from degradation by serum enzymes and can facilitate entry into cells. Still, achieving endosomal escape to allow nucleic acids to enter the cytoplasm has remained a significant barrier, where less than 5% of nanoparticles within the endo-lysosomal pathway are able to transfer their cargo to the cytosol.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!